Home » Newsletters » BioWorld Science

BioWorld Science

April 21, 2011

View Archived Issues

COR-II and substudy evaluate weight loss and blood pressure during Contrave treatment of obesity

Amira Pharma claims new arachidonate 5-lipoxygenase inhibitors

Astellas launches new tablet formulation of Vesicare for overactive bladder

Novel PARP-1 inhibitor HYDAMTIQ is efficacious in models of brain ischemia

FDA approves Rituxan for Wegener's granulomatosis and microscopic polyangiitis

BioSante Pharma licenses cancer vaccines to Aduro BioTech

PET tracer BAY-86-4367 is safe in subjects with primary prostate cancer in phase I study

Expression of transient receptor potential TRPM7 channel predicts poor survival in NPC

Baxter enters definitive agreement to acquire Prism Pharmaceuticals

Presidio Pharma updates progress of HCV NS5A inhibitors PPI-461, PPI-437, PPI-668 and PPI-833

CH-5424802 shows promise in ALK-positive tumors and advances in phase I/II trial in NSCLC

Clopidogrel reduces obliterative airways disease after trachea transplantation in mice

University of Illinois patents new integrin alpha-IIb/beta-3 antagonists

University of California presents new bladder cancer-specific ligand peptides

SciClone acquires NovaMed Pharmaceuticals

Marina Biotech completes enrollment of first cohort in START-FAP trial of CEQ-508

Osta Biotechnologies announces promising preclinical results for OB-28 in Alzheimer's disease

Biothera's second phase II trial of Imprime PGG in NSCLC achieves stage-1 endpoint

New inhibitors of hepatocyte growth factor receptor designed

Genmab and Seattle Genetics form second antibody-drug conjugate collaboration

New modulators of nuclear receptor related 1 receptor claimed

DiaMedica reports preclinical data on DM-204 in type 2 diabetes

Oncolytics Biotech reports interim data from Reolysin trial in metastatic colorectal cancer

Novel 11-beta-HSD1 inhibitors reported by University of Edinburgh

Dynavax commences first phase I trial of DV-1179 in lupus

Enrollment open in phase IIb trial of intravenous omecamtiv mecarbil in acute heart failure

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...